GO:0000719 photoreactive repair: Direct Reversal of UV Pyrimidine Dimers, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0000719 photoreactive repair is the biological process that repairs UV-induced T-T, C-T and C-C pyrimidine dimers by directly reversing the damage to restore the original pyrimidines.
The process is synonymous with pyrimidine-dimer repair by photolyase and is a light-dependent, single-enzyme direct reversal mechanism.
Photoreactive repair is distinct from nucleotide excision repair (NER), which removes and resynthesizes a damaged DNA patch rather than reversing the dimer in situ.
Photoreactive DNA substrates are widely used experimentally to trap and study DNA repair proteins such as RPA, XPA and NER factors [2,6,8].
Loss of photoreactive repair capacity increases UV sensitivity and is linked to cancer predisposition and chemotherapy resistance in model systems [5,7].
CRISPR knockout, point-mutation, knock-in and overexpression cell models enable causal testing of photoreactive repair genes and their interaction with NER and chemotherapy responses.

Description

GO:0000719 photoreactive repair is a biological process that removes ultraviolet (UV)-induced pyrimidine dimers by directly reversing the covalent lesion, restoring the original pyrimidine bases without excision of the DNA strand [2,6]. The term is defined in QuickGO as the repair of UV-induced T-T, C-T and C-C dimers by directly reversing the damage to restore the original pyrimidines, and its synonym is pyrimidine-dimer repair by photolyase. This direct reversal strategy contrasts with nucleotide excision repair (NER), which cuts out and resynthesizes a damaged oligonucleotide [6,8]. Researchers study photoreactive repair because it represents one of the most elegant examples of enzymatic DNA repair: a single light-activated enzyme can monomerize a cyclobutane pyrimidine dimer (CPD) or a 6-4 photoproduct without breaking the phosphodiester backbone. Understanding this process informs UV mutagenesis, skin cancer biology, and the design of photoreactive DNA probes that capture repair complexes for structural and mechanistic analysis [2,6,8]. In the laboratory, photoreactive repair is investigated using defined photoreactive DNA substrates that mimic UV lesions and crosslink repair proteins such as replication protein A (RPA) and XPA [2,6,8]. These tools have revealed how damage recognition, protein-DNA contacts and repair factor recruitment are coordinated, and they provide a foundation for CRISPR-based dissection of repair gene function in human cells [5,7].

photoreactive repair At A Glance

GO ID GO:0000719
GO term photoreactive repair
Ontology biological_process
Synonym pyrimidine-dimer repair by photolyase
Definition The repair of UV-induced T-T, C-T and C-C dimers by directly reversing the damage to restore the original pyrimidines.
Major function Direct reversal of UV-induced pyrimidine dimers without excision of the DNA strand.
Substrates T-T, C-T and C-C pyrimidine dimers, including cyclobutane pyrimidine dimers and 6-4 photoproducts.
Key experimental tool Photoreactive DNA substrates that crosslink repair proteins such as RPA and XPA [2,6,8].
Related pathway Nucleotide excision repair (NER) as a complementary dark repair pathway [6,8].

What Is GO:0000719?

Photoreactive repair (GO:0000719) is the biological process in which UV-induced pyrimidine dimers, specifically T-T, C-T and C-C dimers, are repaired by direct reversal of the covalent damage to regenerate the original pyrimidines. This process is also known as pyrimidine-dimer repair by photolyase. Unlike excision repair pathways that remove a damaged segment, photoreactive repair restores the bases in place, typically using light energy to cleave the cyclobutane ring or the 6-4 adduct [2,6].

Why Is photoreactive repair Important in Cell Biology?

Photoreactive repair is important because it defines a direct, light-dependent mechanism for removing the most common UV-induced DNA lesions, and it provides a conceptual and experimental framework for understanding how cells recognize and reverse pyrimidine dimers [2,6]. The photoreactive DNA tools developed around this process have become standard reagents for trapping and analyzing repair proteins such as RPA and XPA, linking this GO term to the broader NER machinery and to DNA damage response research [2,6,8]. Clinically, defects in DNA repair pathways, including photoreactive repair components, influence UV sensitivity, cancer predisposition and responses to DNA-damaging chemotherapy [5,7].
Defines the direct reversal mechanism for UV-induced T-T, C-T and C-C pyrimidine dimers.
Provides a mechanistic contrast to nucleotide excision repair, which excises and resynthesizes damaged DNA [6,8].
Photoreactive DNA substrates are used to crosslink and identify repair proteins such as RPA and XPA [2,6,8].
Supports studies of UV mutagenesis and skin cancer biology by clarifying how dimers are removed.
Links to chemotherapy resistance because DNA repair capacity modulates responses to DNA-damaging agents [5,7].
Enables CRISPR-based causal testing of repair genes through knockout, point mutation, knock-in and overexpression models.
Informs synthetic lethality strategies in cancer when repair pathways are compromised.
Provides a template for studying direct reversal enzymes and their light-dependent catalytic mechanisms.

What Happens During photoreactive repair?

Damage recognition and substrate binding
In simple terms: The repair enzyme first finds and binds the UV-damaged spot on DNA.
Photoreactive repair begins with recognition of UV-induced pyrimidine dimers, including T-T, C-T and C-C dimers, within the DNA helix. Photoreactive DNA substrates that contain defined lesions have been used to show how repair proteins such as RPA and XPA bind damaged DNA and how bulky photoreactive groups can mimic UV damage to trap repair complexes [2,6,8]. These studies demonstrate that damage recognition is a discrete step that can be uncoupled from catalysis using photoreactive probes [2,6].
Direct reversal of the pyrimidine dimer
In simple terms: Instead of cutting the DNA, the enzyme simply undoes the UV-induced chemical bond.
The defining step of GO:0000719 is direct reversal: the covalent linkage that forms a pyrimidine dimer is broken, restoring the original pyrimidines without excising the DNA strand. This is mechanistically distinct from nucleotide excision repair, in which damaged bases are removed as part of an oligonucleotide and the gap is resynthesized [6,8]. Photoreactive repair therefore preserves the original DNA sequence at the lesion site, which is why it is described as error-free direct reversal.
Light-dependent catalysis
In simple terms: Light provides the energy that drives the repair reaction.
Photoreactive repair is light-dependent, and the term is synonymous with pyrimidine-dimer repair by photolyase. Experimental systems using photoreactive DNA have been instrumental in defining how repair factors engage damaged substrates and how light-activated reversal restores pyrimidines [2,6]. The use of photoreactive nucleotide analogues allows precise control over lesion formation and reversal, enabling mechanistic dissection of the catalytic step [2,8].
Coordination with nucleotide excision repair
In simple terms: Photoreactive repair works alongside other repair systems that cut out damage.
Photoreactive repair does not operate in isolation; it is functionally linked to nucleotide excision repair, which handles bulky lesions that are not directly reversed [6,8]. Crosslinking studies with photoreactive damages have shown that NER proteins such as RPA and XPA interact with damaged DNA and participate in damage verification and repair complex assembly [2,6,8]. This coordination ensures that UV lesions are processed by the appropriate pathway and that repair intermediates are channeled efficiently.
Restoration of original pyrimidines and downstream effects
In simple terms: Once the dimer is reversed, the DNA sequence is back to normal and can be copied accurately.
The endpoint of photoreactive repair is the restoration of the original pyrimidine bases, which allows normal base pairing and replication to resume. Failure to reverse or remove pyrimidine dimers can lead to mutations, and DNA repair capacity more broadly influences sensitivity to DNA-damaging chemotherapy [5,7]. Thus, photoreactive repair contributes to genome maintenance by eliminating a major class of UV photoproducts [2,6].

Key Genes Involved in GO:0000719 photoreactive repair

The following genes and proteins are experimentally linked to photoreactive repair, photoreactive DNA substrate recognition, or the broader DNA repair machinery that coordinates with pyrimidine dimer processing.
GeneMajor RoleResearch Relevance
RPA1Binds single-stranded DNA during repair and replicationPhotoreactive DNA crosslinking studies define RPA function in repair [2,8]
RPA2Subunit of replication protein A involved in DNA damage recognitionUsed to study repair factor recruitment to photoreactive lesions [2,8]
RPA3Subunit of replication protein AComponent of the RPA complex analyzed with photoreactive substrates
XPADamage verification factor in nucleotide excision repairCrosslinks to photoreactive DNA and coordinates with RPA [6,8]
XPCInitiates global genome nucleotide excision repairRelevant to how bulky lesions are recognized alongside photoreactive repair
ERCC1NER endonuclease complex subunitLinks excision repair to processing of UV lesions
XPFNER endonuclease subunitParticipates in incision steps complementary to direct reversal
DDB1Damage-specific DNA binding proteinInvolved in UV damage recognition and repair factor recruitment
DDB2UV-damaged DNA binding proteinRecognizes UV photoproducts and supports repair
SMYD3Histone methyltransferase implicated in DNA repairInhibition impairs DNA repair and reverses chemoresistance
PARP1Poly(ADP-ribose) polymerase in DNA damage responseRelevant to synthetic lethality and repair inhibitor studies
BRCA1Homologous recombination and DNA repairRepair pathway context for chemotherapy response
BRCA2Homologous recombination repairRepair pathway context for synthetic lethality
TP53DNA damage response and apoptosisModulates cellular responses to unrepaired UV damage
PCNAReplication processivity factor at repair sitesCoordinates repair and replication at damaged templates
POLR2ARNA polymerase II subunitTranscription-coupled repair context for UV lesions
CUL4ACullin-RING ligase component in DNA damage responseRegulates repair factor turnover after UV damage

How Is photoreactive repair Regulated?

Photoreactive repair and its coordination with nucleotide excision repair are regulated at multiple levels, including damage recognition, protein-protein interactions and post-translational control of repair factors [2,6,8]. Photoreactive DNA crosslinking studies show that RPA and XPA binding to damaged DNA is a regulated step that can be influenced by the chemical nature of the lesion and the presence of bulky photoreactive groups [2,6,8]. In cancer cells, DNA repair capacity is modulated by chromatin-modifying enzymes such as SMYD3, whose inhibition impairs repair responses and reverses chemoresistance. PARP inhibitor sensitivity and synthetic lethality further demonstrate that repair pathway activity is tunable and clinically relevant.

photoreactive repair and Human Disease

GeneDisease / BiologyPotential Experimental Model
SMYD3Chemotherapy resistance and impaired DNA repairKnockout or point-mutation cancer cell lines treated with chemotherapy
PARP1Synthetic lethality and PARP inhibitor resistanceKnockout pancreatic cancer models with PARP inhibitor treatment
BRCA1Homologous recombination deficiency and cancerKnockout or knock-in models for synthetic lethality studies
BRCA2Homologous recombination deficiency and cancerKnockout models for repair pathway dependency
TP53DNA damage response and apoptosisPoint-mutation and knockout models for UV and chemotherapy response
UV sensitivity and skin cancer biology
Defective processing of UV-induced pyrimidine dimers increases UV sensitivity and mutagenesis, which are central to skin cancer development [2,6]. Photoreactive repair provides a direct reversal mechanism for these lesions, and its experimental dissection using photoreactive DNA substrates has clarified how repair proteins recognize UV damage [2,6,8]. Understanding this pathway helps explain why cells with compromised repair capacity accumulate mutations after UV exposure.
Chemotherapy resistance and DNA repair inhibitors
DNA repair capacity influences responses to DNA-damaging chemotherapy, and inhibition of repair-associated enzymes can reverse chemoresistance. SMYD3 inhibition impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance, linking repair regulation to treatment outcomes. Similarly, synthetic lethality and PARP inhibitor resistance studies in pancreatic cancer highlight how repair pathway status determines drug sensitivity.
Synthetic lethality in cancer therapy
Synthetic lethality approaches exploit repair pathway dependencies to selectively kill cancer cells. Enantiomer differential activity studies in pancreatic cancer demonstrate that repair status and PARP inhibitor resistance can be probed experimentally. These concepts extend to photoreactive repair-related genes, whose loss may create vulnerabilities that can be targeted therapeutically [5,7].

From photoreactive repair-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of a candidate repair gene increase UV sensitivity?CRISPR knockout cell line followed by UV survival assay
Does a specific repair gene mutation alter pyrimidine dimer processing?Point-mutation knock-in cell line with photoreactive DNA substrate assays
Can a repair gene be tagged for localization studies?Tagged knock-in cell line expressing fluorescent or epitope-tagged protein
Does overexpression of a repair gene enhance damage reversal?Overexpression cell model with controlled induction
Which genes are required for survival after DNA-damaging chemotherapy?CRISPR library screening in cancer cell lines [5,7]
How does repair pathway status affect PARP inhibitor sensitivity?Knockout or point-mutation models treated with PARP inhibitors

How to Study the photoreactive repair Process

MethodWhat It MeasuresTypical Application
Photoreactive DNA crosslinkingProtein-DNA contacts at defined lesionsIdentifying RPA and XPA binding to damaged DNA [2,6,8]
UV survival assayCellular sensitivity to UV-induced damageTesting repair gene knockout or point-mutation lines
CRISPR library screeningGenes required for survival under DNA damageDiscovering repair pathway dependencies [5,7]
Western blot and co-immunoprecipitationProtein expression and interactionValidating repair complex assembly [6,8]
Fluorescence imagingSubcellular localization of repair factorsTracking tagged repair proteins after damage
Chemotherapy sensitivity assayResponse to DNA-damaging drugsTesting repair inhibitors and resistance mechanisms [5,7]
Bioinformatics pathway analysisEnrichment of repair-related gene setsInterpreting screening and transcriptomic data
Photoreactive DNA substrate assays
Photoreactive DNA substrates containing defined lesions are used to crosslink and identify repair proteins such as RPA and XPA [2,6,8]. These assays allow precise control over damage chemistry and enable mechanistic studies of damage recognition and repair complex assembly [2,6].
UV survival and damage sensitivity assays
Cell survival after UV irradiation measures the functional capacity of repair pathways, including photoreactive repair and nucleotide excision repair [2,6]. Knockout or point-mutation cell lines can be compared to parental cells to determine the contribution of specific genes to UV resistance.
CRISPR screening and bioinformatics
CRISPR library screening combined with bioinformatics identifies genes required for survival under DNA-damaging conditions and maps repair pathway dependencies [5,7]. These approaches can nominate photoreactive repair-related candidates for follow-up validation.
Protein interaction and crosslinking analysis
Crosslinking of nucleotide excision repair proteins with DNA containing photoreactive damages reveals direct protein-DNA contacts and interaction networks [6,8]. Such experiments define how repair factors assemble on damaged templates and coordinate with direct reversal mechanisms [2,6].

How CRISPR Can Be Used to Study GO:0000719 photoreactive repair

Knockout

CRISPR knockout of candidate repair genes enables loss-of-function studies to test whether a gene is required for photoreactive repair or for survival after UV and chemotherapy [5,7]. Knockout cell lines can be challenged with photoreactive DNA substrates or DNA-damaging agents to quantify repair defects.

Point Mutation

Point-mutation knock-in models allow precise testing of catalytic residues or regulatory sites within repair genes. Such models are valuable for distinguishing direct reversal activity from scaffolding functions in DNA repair complexes [2,6].

Knock-in

Knock-in of tagged or reporter alleles supports localization, interaction and kinetic studies of repair proteins. Tagged knock-in lines can be used with photoreactive DNA substrates to track repair factor recruitment in live cells [2,8].

Overexpression

Overexpression models test whether increased levels of a repair gene enhance damage reversal or alter chemotherapy sensitivity. These models complement knockout studies by probing gain-of-function effects in repair pathways [5,7].

How EDITGENE Supports photoreactive repair Research

Researchers studying photoreactive repair-related genes often need to determine whether a candidate gene is causally involved in pyrimidine dimer processing, DNA damage sensitivity or chemotherapy response. EDITGENE provides CRISPR-based cell model services that enable knockout, point-mutation, knock-in and overexpression studies, together with library screening and bioinformatics support, to accelerate mechanistic and translational research on GO:0000719 and its associated repair networks.
Contact EDITGENE today to design your custom CRISPR model for photoreactive repair research.

Frequently Asked Questions About photoreactive repair

Photoreactive repair (GO:0000719) is the repair of UV-induced T-T, C-T and C-C dimers by directly reversing the damage to restore the original pyrimidines [2,6].
The GO ID is GO:0000719, a biological_process term with the synonym pyrimidine-dimer repair by photolyase.
Genes and proteins experimentally linked to this process and its coordination include RPA1, RPA2, RPA3, XPA, XPC, ERCC1, XPF, DDB1, DDB2, SMYD3, PARP1, BRCA1 and BRCA2 [2,5,6,7,8].
Photoreactive repair directly reverses pyrimidine dimers without excising DNA, whereas nucleotide excision repair removes a damaged oligonucleotide and resynthesizes the gap [2,6,8].
Photoreactive DNA substrates that crosslink repair proteins such as RPA and XPA are widely used, along with UV survival assays and CRISPR-based models [2,6,8].
DNA repair capacity, including pathways that process UV and chemotherapy-induced damage, influences cancer predisposition, chemotherapy resistance and synthetic lethality [5,7].
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of repair gene function and drug sensitivity [5,7].
Defective processing of UV-induced dimers is linked to UV sensitivity and skin cancer biology, and repair defects influence chemotherapy resistance in cancer [2,5,6,7].
The synonym is pyrimidine-dimer repair by photolyase.
Select knockout models for loss-of-function, point-mutation models for catalytic residues, knock-in models for localization, and overexpression models for gain-of-function studies [2,5,6,7,8].

Conclusion

GO:0000719 photoreactive repair defines the direct reversal of UV-induced T-T, C-T and C-C pyrimidine dimers, a process synonymous with pyrimidine-dimer repair by photolyase [2,6]. Its mechanistic distinction from nucleotide excision repair and its experimental accessibility through photoreactive DNA substrates make it a valuable model for DNA damage recognition and repair [2,6,8]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with library screening and bioinformatics, provide a robust path to test the causal roles of repair genes in UV sensitivity, cancer biology and chemotherapy response [5,7]. EDITGENE supports these studies with publication-ready cell models and analysis services.

References

  1. 2. Rechkunova NI et al.. 2020. Photoreactive DNA as a Tool to Study Replication Protein A Functioning in DNA Replication and Repair.. Photochem Photobiol 96(2):440-449 PMID: 32017119
  2. 5. Sanese P et al.. 2024. The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance.. J Exp Clin Cancer Res 43(1):151 PMID: 38812026
  3. 6. Maltseva EA et al.. 2008. Crosslinking of nucleotide excision repair proteins with DNA containing photoreactive damages.. Bioorg Chem 36(2):77-84 PMID: 18191172
  4. 7. Masi M et al.. 2025. Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.. Cell Death Discov 11(1):106 PMID: 40091075
  5. 8. Maltseva EA et al.. 2006. Interaction of nucleotide excision repair factors RPA and XPA with DNA containing bulky photoreactive groups imitating damages.. Biochemistry (Mosc) 71(3):270-8 PMID: 16545063
Contact Us
*
*
*
*
How did you hear about us: